M11.26 Other chondrocalcinosis, knee

Name of the Condition

• Other chondrocalcinosis, knee

Summary

Other chondrocalcinosis, knee refers to the deposition of calcium-containing crystals in the knee joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, knee is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the knee’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Knee trauma or surgery.

Symptoms

• Knee pain, swelling, and stiffness.
• Warmth and redness over the affected joint.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves joint aspiration to analyze synovial fluid for crystal type, imaging (e.g., X-ray, MRI) to assess joint damage, and clinical evaluation of symptoms. Crystal identification is key to distinguishing this condition from other arthritic disorders.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Corticosteroid injections to reduce acute symptoms.
• Physical therapy to improve mobility and strength.
• Management of underlying metabolic conditions.
• Surgical intervention for severe joint damage.

Prognosis and Follow-Up

Prognosis depends on the extent of joint damage and response to treatment. Regular follow-up is recommended to monitor symptoms, adjust therapy, and address complications. Early intervention may help preserve joint function.

Complications

• Chronic joint pain and stiffness.
• Progressive cartilage loss or osteoarthritis.
• Recurrent inflammatory episodes.
• Reduced mobility or disability.

Lifestyle & Prevention

• Maintain a healthy weight to reduce knee stress.
• Avoid repetitive high-impact activities.
• Manage underlying metabolic conditions.
• Use supportive footwear or braces if needed.
• Stay active with low-impact exercises (e.g., swimming).

When to Seek Professional Help

Seek care if knee pain is severe, persistent, or worsening; if swelling or redness develops; or if mobility is significantly impaired. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Document the specific joint (knee) and confirm the exclusion of CPPD or hydroxyapatite crystals. Ensure clinical notes support the diagnosis and crystal type, as this code is site-specific and requires differentiation from other chondrocalcinosis subtypes.